Incidenza del no-reflow calcolata su oltre 19 000 angioplastiche primarie ed elettive in un singolo centro ad alto volume

Translated title of the contribution: No-reflow phenomenon calculated in over 19,000 primary and elective angioplasty in a high-volume single center

Alessandro Durante, Azeem Latib, Giuseppe Pizzetti, Antonio Colombo, Paolo G. Camici

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background. The no-reflow (NR) phenomenon is frequent in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). However, its real incidence and prognostic significance, so far derived from relatively small patient cohorts, remain poorly defined. Methods. We have retrospectively analyzed 19 290 consecutive PCI performed at our hospital between January 1998 and November 2010. NR was defined as a TIMI flow .2 at the end of the PCI. Results. In the 1257 patients with STEMI, NR occurred in 9.4% of cases and was more common when the left anterior descending coronary artery was the culprit vessel. STEMI-NR patients had longer ischemic times and more frequently multivessel disease. In the STEMI-NR group, glycoprotein IIb/IIIa inhibitors were used in 60.2%, nitroprusside in 39.6%, thrombus aspiration in 10.7% and adenosine in 8.7%. In the remaining 18 033 patients without STEMI undergoing PCI, the NR phenomenon occurred only in 0.2% of cases. STEMI- NR patients had lower left ventricular ejection fraction at discharge (50.3 ± 7.2 vs 44.9 ± 8.4%; p

Original languageItalian
Pages (from-to)110-115
Number of pages6
JournalGiornale Italiano di Cardiologia
Volume15
Issue number2
Publication statusPublished - 2014

Fingerprint

No-Reflow Phenomenon
Angioplasty
Percutaneous Coronary Intervention
Platelet Glycoprotein GPIIb-IIIa Complex
Nitroprusside
Stroke Volume
Adenosine
ST Elevation Myocardial Infarction
Coronary Vessels
Thrombosis
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Incidenza del no-reflow calcolata su oltre 19 000 angioplastiche primarie ed elettive in un singolo centro ad alto volume. / Durante, Alessandro; Latib, Azeem; Pizzetti, Giuseppe; Colombo, Antonio; Camici, Paolo G.

In: Giornale Italiano di Cardiologia, Vol. 15, No. 2, 2014, p. 110-115.

Research output: Contribution to journalArticle

Durante, Alessandro ; Latib, Azeem ; Pizzetti, Giuseppe ; Colombo, Antonio ; Camici, Paolo G. / Incidenza del no-reflow calcolata su oltre 19 000 angioplastiche primarie ed elettive in un singolo centro ad alto volume. In: Giornale Italiano di Cardiologia. 2014 ; Vol. 15, No. 2. pp. 110-115.
@article{8f8f2edabfbc4fae84c4ccdecab00639,
title = "Incidenza del no-reflow calcolata su oltre 19 000 angioplastiche primarie ed elettive in un singolo centro ad alto volume",
abstract = "Background. The no-reflow (NR) phenomenon is frequent in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). However, its real incidence and prognostic significance, so far derived from relatively small patient cohorts, remain poorly defined. Methods. We have retrospectively analyzed 19 290 consecutive PCI performed at our hospital between January 1998 and November 2010. NR was defined as a TIMI flow .2 at the end of the PCI. Results. In the 1257 patients with STEMI, NR occurred in 9.4{\%} of cases and was more common when the left anterior descending coronary artery was the culprit vessel. STEMI-NR patients had longer ischemic times and more frequently multivessel disease. In the STEMI-NR group, glycoprotein IIb/IIIa inhibitors were used in 60.2{\%}, nitroprusside in 39.6{\%}, thrombus aspiration in 10.7{\%} and adenosine in 8.7{\%}. In the remaining 18 033 patients without STEMI undergoing PCI, the NR phenomenon occurred only in 0.2{\%} of cases. STEMI- NR patients had lower left ventricular ejection fraction at discharge (50.3 ± 7.2 vs 44.9 ± 8.4{\%}; p",
keywords = "Ischemic heart disease, Myocardial infarction, No-reflow phenomenon, Reperfusion injury",
author = "Alessandro Durante and Azeem Latib and Giuseppe Pizzetti and Antonio Colombo and Camici, {Paolo G.}",
year = "2014",
language = "Italian",
volume = "15",
pages = "110--115",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "2",

}

TY - JOUR

T1 - Incidenza del no-reflow calcolata su oltre 19 000 angioplastiche primarie ed elettive in un singolo centro ad alto volume

AU - Durante, Alessandro

AU - Latib, Azeem

AU - Pizzetti, Giuseppe

AU - Colombo, Antonio

AU - Camici, Paolo G.

PY - 2014

Y1 - 2014

N2 - Background. The no-reflow (NR) phenomenon is frequent in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). However, its real incidence and prognostic significance, so far derived from relatively small patient cohorts, remain poorly defined. Methods. We have retrospectively analyzed 19 290 consecutive PCI performed at our hospital between January 1998 and November 2010. NR was defined as a TIMI flow .2 at the end of the PCI. Results. In the 1257 patients with STEMI, NR occurred in 9.4% of cases and was more common when the left anterior descending coronary artery was the culprit vessel. STEMI-NR patients had longer ischemic times and more frequently multivessel disease. In the STEMI-NR group, glycoprotein IIb/IIIa inhibitors were used in 60.2%, nitroprusside in 39.6%, thrombus aspiration in 10.7% and adenosine in 8.7%. In the remaining 18 033 patients without STEMI undergoing PCI, the NR phenomenon occurred only in 0.2% of cases. STEMI- NR patients had lower left ventricular ejection fraction at discharge (50.3 ± 7.2 vs 44.9 ± 8.4%; p

AB - Background. The no-reflow (NR) phenomenon is frequent in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). However, its real incidence and prognostic significance, so far derived from relatively small patient cohorts, remain poorly defined. Methods. We have retrospectively analyzed 19 290 consecutive PCI performed at our hospital between January 1998 and November 2010. NR was defined as a TIMI flow .2 at the end of the PCI. Results. In the 1257 patients with STEMI, NR occurred in 9.4% of cases and was more common when the left anterior descending coronary artery was the culprit vessel. STEMI-NR patients had longer ischemic times and more frequently multivessel disease. In the STEMI-NR group, glycoprotein IIb/IIIa inhibitors were used in 60.2%, nitroprusside in 39.6%, thrombus aspiration in 10.7% and adenosine in 8.7%. In the remaining 18 033 patients without STEMI undergoing PCI, the NR phenomenon occurred only in 0.2% of cases. STEMI- NR patients had lower left ventricular ejection fraction at discharge (50.3 ± 7.2 vs 44.9 ± 8.4%; p

KW - Ischemic heart disease

KW - Myocardial infarction

KW - No-reflow phenomenon

KW - Reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=84896367580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896367580&partnerID=8YFLogxK

M3 - Articolo

VL - 15

SP - 110

EP - 115

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 2

ER -